| 000 | 01366 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516172828.0 | ||
| 264 | 0 | _c20140516 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1545-9616 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFellner, Michael J | |
| 245 | 0 | 0 |
_aEtanercept urticaria in a patient with psoriasis desensitized using a new method. _h[electronic resource] |
| 260 |
_bJournal of drugs in dermatology : JDD _cOct 2013 |
||
| 300 |
_a1168-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDesensitization, Immunologic _xmethods |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKeratoderma, Palmoplantar _xdrug therapy |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aPsoriasis _xcomplications |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aUrticaria _xchemically induced |
| 700 | 1 | _aYohe, Nicholas | |
| 773 | 0 |
_tJournal of drugs in dermatology : JDD _gvol. 12 _gno. 10 _gp. 1168-9 |
|
| 999 |
_c23134468 _d23134468 |
||